Quest PharmaTech (TSXV:QPT) Forward Dividend Yield % : 0.00% (As of Jun. 10, 2024)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Forward Dividend Yield %?

As of today (2024-06-10), the Forward Annual Dividend Yield of Quest PharmaTech is 0.00%.

As of today (2024-06-10), the Trailing Annual Dividend Yield of Quest PharmaTech is 0.00%.

TSXV:QPT's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.66
* Ranked among companies with meaningful Forward Dividend Yield % only.

Quest PharmaTech's Dividends per Share for the three months ended in Jan. 2024 was C$0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Quest PharmaTech was -2.20% per year. The lowest was -20.60% per year. And the median was -11.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Quest PharmaTech's Forward Dividend Yield %

For the Biotechnology subindustry, Quest PharmaTech's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest PharmaTech's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Forward Dividend Yield % falls into.

Quest PharmaTech Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Quest PharmaTech (TSXV:QPT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Quest PharmaTech Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines